Epigenetic mechanisms of Non-Invasive Brain Stimulation: A Systematic Review of Human and Preclinical Evidence
Abstract
Non-invasive brain stimulation (NIBS) produces clinical and behavioural effects persisting weeks to months beyond stimulation. This persistence is typically attributed to LTP- and LTD-like synaptic plasticity, yet short-lived synaptic events alone cannot explain it; epigenetic mechanisms, the leading candidate substrate, have never been systematically evaluated. Following PRISMA 2020, we searched PubMed/MEDLINE and Europe PMC to June 2026 (2,089 records; 1,941 de-duplicated). Twenty-two studies were eligible: ten human, ten preclinical, and two invasive cervical-VNS studies retained for sensitivity analysis. Among 18 interventional studies, 17 reported significant epigenetic change (94%; p = 1.45×10⁻⁴), driven by the controlled animal tier (10/10; p = 0.002); the human stream alone (5/6) was non-significant (p = 0.22). Adjusting for publication bias, the pooled signal held under a moderately conservative null (p₀ = 0.7, p = 0.020) but not a strongly conservative one (p₀ = 0.8, p = 0.15). Effects spanned histone modifications, DNA methylation, non-coding RNAs, and epigenetic enzymes. Histone acetylation was the most compelling pathway, supported by causal pharmacological rescue in rodent rTMS and tDCS models. DNA methylation showed an "epigenetic homeostat" pattern, normalising stress-induced aberrations at promoters including BDNF and COMT. Non-coding RNAs formed the largest stream, with circulating miR-146a-5p recurring across rTMS trials. BDNF emerged as a convergent node, also predicting rTMS response via baseline methylation and circulating microRNAs. Coverage is skewed: rTMS and tDCS dominate, tVNS is sparse, tACS/tRNS uninvestigated. NIBS is consistently associated with epigenetic remodelling across mechanisms and species, positioning chromatin regulation as a primary substrate for durable neuromodulatory after-effects.
Related
- A pilot study of invasive vagus nerve stimulation in Chinese patients with Alzheimer’s disease: preliminary results on safety, cognition, and biomarkers
- IL-23 licenses the transition from preclinical autoimmunity to inflammatory arthritis through IL-17A-dependent mechanisms
- Stimulation-stability and preclinical bench testing of a new auditory nerve interface.
- Ameliorating effects and mechanisms of therapeutic electrical stimulation on the recurrent laryngeal nerve injury model in rats
- Drug-induced gastrointestinal toxicity: from pathophysiological mechanisms to human-relevant preclinical models
BibTeX
@misc{kang2026epigenetic,
title = {{Epigenetic mechanisms of Non-Invasive Brain Stimulation: A Systematic Review of Human and Preclinical Evidence}},
author = {June Kang and JeYoung Jung},
howpublished = {PsyArXiv},
year = {2026},
month = sep,
doi = {10.31234/osf.io/27dwb_v1},
url = {https://osf.io/preprints/psyarxiv/27dwb_v1/},
note = {CC BY 4.0},
}
RIS
TY - UNPB
TI - Epigenetic mechanisms of Non-Invasive Brain Stimulation: A Systematic Review of Human and Preclinical Evidence
AU - June Kang
AU - JeYoung Jung
PY - 2026
DA - 2026/09/20
PB - PsyArXiv
DO - 10.31234/osf.io/27dwb_v1
UR - https://osf.io/preprints/psyarxiv/27dwb_v1/
AB - Non-invasive brain stimulation (NIBS) produces clinical and behavioural effects persisting weeks to months beyond stimulation. This persistence is typically attributed to LTP- and LTD-like synaptic plasticity, yet short-lived synaptic events alone cannot explain it; epigenetic mechanisms, the leading candidate substrate, have never been systematically evaluated. Following PRISMA 2020, we searched PubMed/MEDLINE and Europe PMC to June 2026 (2,089 records; 1,941 de-duplicated). Twenty-two studies were eligible: ten human, ten preclinical, and two invasive cervical-VNS studies retained for sensitivity analysis. Among 18 interventional studies, 17 reported significant epigenetic change (94%; p = 1.45×10⁻⁴), driven by the controlled animal tier (10/10; p = 0.002); the human stream alone (5/6) was non-significant (p = 0.22). Adjusting for publication bias, the pooled signal held under a moderately conservative null (p₀ = 0.7, p = 0.020) but not a strongly conservative one (p₀ = 0.8, p = 0.15). Effects spanned histone modifications, DNA methylation, non-coding RNAs, and epigenetic enzymes. Histone acetylation was the most compelling pathway, supported by causal pharmacological rescue in rodent rTMS and tDCS models. DNA methylation showed an "epigenetic homeostat" pattern, normalising stress-induced aberrations at promoters including BDNF and COMT. Non-coding RNAs formed the largest stream, with circulating miR-146a-5p recurring across rTMS trials. BDNF emerged as a convergent node, also predicting rTMS response via baseline methylation and circulating microRNAs. Coverage is skewed: rTMS and tDCS dominate, tVNS is sparse, tACS/tRNS uninvestigated. NIBS is consistently associated with epigenetic remodelling across mechanisms and species, positioning chromatin regulation as a primary substrate for durable neuromodulatory after-effects.
ER -